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ABSTRACT
Human genes use various mechanisms to generate
different transcripts having different exon content,
which in turn generate multiple protein isoforms
havingdifferentialandevenoppositebiologicalactiv-
ities. To understand the biological consequences
of gene transcriptional activity modulation, it is nec-
essarytointegratethecapabilityofgenestogenerate
distinct functional products, particularly because
transcriptional stimuli also affect the exon content
of their target gene products. For this purpose, we
have developed a bioinformatics suite, FAST DB,
which defines easily and accurately the exon content
ofallknowntranscriptsproducedbyhumangenes.In
addition, several tools have been developed, includ-
ing a graphical presentation of all gene products, a
sequence multi-alignment of all gene transcripts
and an in silico PCR computer program. The FAST
DB interface also offers extensive links to website
resources for promoter analysis and transcription
factor binding site prediction, splicing regulatory
sequenceprediction,aswellas50-and30-untranslated
regionanalysis.FASTDBhasbeendesignedtofacili-
tate studies that integrate transcriptional and post-
transcriptional events to investigate the expression
regulation of human gene products.
INTRODUCTION
About 95% of human genes contain exons (between 7 and 12
in average) separated by introns. Exons contain the informa-
tion necessary for the production of proteins, whereas introns
are removed during the splicing process that gives rise to
messenger RNAs (mRNAs). The mRNAs are then exported
to the cytosol where they are translated. Owing to the presence
of exons separated by introns, a single gene can produce
different mRNAs having various exon contents. At its 50
end or within internal introns, a given gene can have different
promoters driving the production of transcripts that have dif-
ferent 50-untranslated regions (50-UTRs) and that sometimes
encode protein isoforms with different N-terminal domains
(1,2). At its 30 end or within internal exons and/or introns,
a given gene can have different transcriptional termination
sequences and/or polyadenylation sites allowing the produc-
tion of different transcripts that have different 30-UTRs
and that eventually encode protein isoforms with different
C-terminal domains (3–5). During the splicing process, dif-
ferent introns (or parts of introns) and different exons (or parts
of exons) can be alternatively spliced (6–10). A given intron
can be retained in an mRNA molecule (intron retention),
whereas a given exon can be skipped (exon skipping or
exon cassette). The 50 or the 30 end of a given intron can
be differentially selected (alternative 50-o r3 0-splicing site,
respectively), which modiﬁes the size of the exons included
in the mRNA. It is estimated that 75% of these events occur in
the translated regions of mRNAs and have consequences at
the protein level (6–9,11). Alternative splicing events either
generate splice variants encoding truncated proteins by the
introduction of a stop codon, or yield protein isoforms that
contain different domains. This allows a single gene to pro-
duce proteins with different properties regarding their stability
or cellular localization, their ability to be regulated by post-
translational modiﬁcations and to respond to signaling path-
ways, and their ability to interact with partners and/or to per-
form enzymatic reactions (6–9). The biological importance of
such mechanisms is illustrated by genes involved in cell death
as a single gene can produce different protein isoforms with
either pro- or anti-apoptotic effects (12). Moreover, the human
sequencing project and the cloning and sequencing of an
increasing number of human transcripts reveal that most
human genes (between 40 and 70%) generate different tran-
scripts, which contributes to increase the human proteome
diversity encoded by a limited number of genes (6–9,13,14).
Owing to the production of different translatable mRNAs
from a given gene, it is not possible to predict the biological
consequences resulting from gene transcriptional modulation
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doi:10.1093/nar/gki738only. This is particularly important because a transcriptional
stimulus can ‘switch’ the promoter that drives the production
of its gene products, and can also change the nature (exon
content) of its target gene products. Indeed, the promoter
identity driving the expression of a gene can affect the nature
of the splice variants produced by this gene and, as we have
shown, transcriptional stimuli, such as steroid hormones,
simultaneously control the transcriptional rate of their target
genes and the nature (exon content) of the spliced variant
produced (15–18). Consistent with these observations, differ-
ent transcription factors or transcriptional coregulators have
different effects on splicing and 30-end processing (17–23). In
this context, studies of gene expression regulation need to
account for the capability of human genes to produce different
transcripts (24–26). For this reason, we developed a bioinfor-
matics suite, named FAST DB (Friendly Alternative Splicing
and Transcripts Database), that allows for deﬁning easily and
accurately the exon content of the different known transcripts
produced by human genes based on a computerized analysis of
human and mouse cDNAs and human expressed sequence
tags (ESTs) libraries. In addition, a multi-alignment of all
the transcript sequences of a given gene allows for visualizing
thecommonandspeciﬁcsequencesofthesetranscripts.There-
fore, it becomes very easy to design probes for downstream
experimental applications, in particular PCR ampliﬁcation.
Thanks to FAST DB interface, users can design primers in a
few minutes for PCR ampliﬁcation of either all the gene prod-
ucts or speciﬁc variants, as well as for the co-ampliﬁcation of
splice variants giving rise to PCR products of different sizes.
In addition, several links to various website resources are
provided for the analysis of promoter regions and the analysis
of 50- and 30-UTRs, as well as links to other splicing databases
recently developed (27–32). Therefore, FAST DB is a bioin-
formatics tool designed for a rapid, extensive and accurate
search to support integrated studies of gene transcriptional
and post-transcriptional regulation.
MATERIALS AND METHODS
Filling FAST DB
All data contained in FAST DB were obtained through an
informatics analysis of sequences available from public
libraries. FAST DB was developed in PERL v5.8.5 (www.
perl.org) using Bio::EnsEMBL, CGI, DBI, BioPerl, GD and
PDF::API2 modules (www.cpan.org) on an AMD Athlon64
3000+ processor with 1.5 Go of RAM and with the Mandrake
10.1Linuxdistribution(www.mandrakelinux.com).TheFAST
DB algorithm recovered all the exon sequences deﬁned in
EnsEMBL version 26 (homo_sapiens_core_26_35 database)
and each of these exons was ‘blasted’ against two cDNA
databanks using standalone BLAST v2.2.10. A full-length
transcript databank was downloaded from the UCSC website
(genome.ucsc.edu) and a partial mRNA databank was down-
loaded from the NCBI website (www.ncbi.nlm.nih.gov).
These two databanks were formatted using Formatdb (‘for-
matdb -i downloaded_databank -pF -oT -sT’). All the recov-
eredtranscriptswithanE-value <10
 40(Blastwasmadeusing
Bio::ToolsRun::StandAloneBlast and transcript sequences
were recovered using fastacmd) were aligned against genomic
sequences using sim4. By parsing the sim4 output and using
strict criteria (see Supplementary Material), each transcript
was then selected or excluded. The sim4 output also allowed
for deﬁning the different exons contained in each transcript.
These exons were called ‘transcript exons’ and were clustered
by genomic position. ‘Genomic exons’ were deﬁned using the
more frequent ﬁrst and last position of the different clustered
‘transcript exon’.
To deﬁne alternative events generating the different prod-
ucts of a single gene, the FAST DB algorithm compared each
‘transcript exon’ with its corresponding ‘genomic exon’.
FAST DB deﬁned seven types of events (see Supplementary
Material). To be deﬁned as an alternative ﬁrst exon, a ‘tran-
script exon’ had to be the ﬁrst exon of at least one transcript
and, if there were other internalexons at this genomicposition,
it had to start at least 10 nt upstream of the ﬁrst position of the
corresponding ‘genomic exon’. To be deﬁned as an alternative
last exon, a ‘transcript exon’ had to be the last exon of at least
one transcript and, if there were other internal exons at this
genomicposition, it hadtoend atleast 10 ntdownstream ofthe
last position of the corresponding ‘genomic exon’. The FAST
DB algorithm also deﬁned several splicing events. An ‘alter-
native 30-splice site’ event was deﬁned when the ﬁrst position
ofa‘transcriptexon’ was different fromtheﬁrst positionofthe
corresponding ‘genomic exon’. An ‘alternative 50-splice site’
event was deﬁned when the last position of a ‘transcript exon’
was different from the last position of the corresponding
‘genomic exon’. An ‘intron retention’ event was deﬁned
when a whole intronic sequence was included in at least
one ‘transcript exon’ sequence. FAST DB also deﬁned an
‘internal exon deletion’ (IED) event when a ‘transcript
exon’ presented an internal sequence deletion compared
with the corresponding ‘genomic exon’ sequence. Such
deleted sequences correspond in fact to small introns that
are frequently not spliced out (data not shown). Finally, an
‘exon skipping’ event was deﬁned when at least one transcript
had no deﬁned ‘genomic exon’.
Once the ‘genomic exons’ and the alternative events were
deﬁned, the FAST DB algorithm ﬁlled a MySQL database
(using DBI module for PERL). FAST DB used MySQL
v4.0.20 (www.mysql.com). To decrease the loading time of
its website, the FAST DB algorithm makes PNG ﬁles of gene
and transcript representations (using GD module for PERL)
and PDF ﬁles (using PDF::API2 module for PERL) and stores
these ﬁles on aserver.The samealgorithm was usedforhuman
ESTs and mouse cDNAs analyses.
Multi-alignment and in silico PCR
FAST DB multi-alignment is available by using the FAST DB
graphical interface. This interface was created using PERL
(CGI module) on an APACHE server v2.0.50 (www.
apache.org). FAST DB multi-alignment was performed using
Clustalw and Partial Order Alignment. For a given gene, the
sequences of ‘transcript exons’ corresponding to one ‘genomic
exon’ were aligned using Clustalw. The results for each
‘genomic exon’ position were then assembled to present the
multi-alignment of the different cDNAs. ‘Transcript exons’
containing a retained intron were each divided into two exons
and one intron (or more intron/exon in case of multiple con-
secutive retained introns). Each exon was aligned with its
corresponding ‘genomic exons’, and then the intron sequence
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presenting an IED event, all the corresponding ‘transcript
exons’ were aligned using Partial Order Alignment with the
global alignment option (33,34). Nevertheless, owing to multi-
alignment programming difﬁculties, in particular when ‘tran-
script exon’ sequences poorly overlap, some ‘transcript exons’
are not properly aligned (see Supplementary Material). To
overcome this limitation, the sim4 alignment of each transcript
sequence against the genomic sequence is made available (see
below).
Housekeeping genes
We have selected a set of 707 housekeeping (HK) genes by
compiling results from several reports deﬁning HK genes
based on the presence of their transcripts in a wide variety
of tissues (35–38). We have linked all these genes with the
FAST DB database. We have then excluded redundant genes,
haveassigned a unique ID toeach ofthesegenes and have set a
new table of 707 ID to do statistical analyses.
RESULTS
By comparing the sequence of human genes with the sequence
of their transcripts available from public libraries, the FAST
DB algorithm provides the genomic organization and the exon
content of transcripts corresponding to >12000 human genes
(see Materials and Methods and Supplementary Material).
FAST DB contains genes deﬁned by ‘good quality’ cDNAs
only. Genes missing in FAST DB might not be deﬁned by
human cDNAs or ‘good quality’ cDNAs (see Supplementary
Material).
More than 150000 exons (10 exons per gene on average)
have been deﬁned in FAST DB using 80000 transcripts
(6 transcripts per gene on average). All the events deﬁned
by FAST DB and yielding different transcripts from single
genes are based on a computerized analysis of known full-
length and partial human cDNAs. For each gene, the analysis
of the corresponding ESTs has been independently made
available, which allows the prediction of additional events
(see below). When possible, a similar analysis has been per-
formed for mouse orthologous genes, allowing inter-species
comparison (see below).
The FAST DB ‘SEARCH PAGE’ (http://193.48.40.18/
fastdb/) offers different ways of accessing a given gene.
FAST DB can be queried using either any name of the
gene (see Supplementary Material and Figure 1A, item 1)
or a partial sequence of the gene of interest, which will be
identiﬁed by a ‘BLAST’ search (Figure 1A, item 2). Alterna-
tively, multiple queries are possible by uploading ﬁles con-
taining a list of genes of interest (ENsEMBL stable ID)
(Figure 1A, item 3 and see User’s guide). The list of FAST
DB links to all the genes obtained by this query might be saved
for further analysis. This multiple query interface is of
interest to assist in designing custom made microarrays.
After running the search engine, a gene or a list of genes is
provided as a query result. By clicking on the requested gene,
FAST DB opens the ‘MAIN PAGE’ of the gene. For example,
Figure 1B shows the FAST DB analysis corresponding to
the human gene of the growth hormone releasing hormone
receptor (GHRHR).
Analysis of the exon content of human gene products
In addition to general information regarding a requested
gene through links to different website resources, such as
EnsEMBL, NCBI, ExPASy (Figure 1B, item 1) and the
UCSC genome browser (Figure 1B, item 2), the ‘MAIN
PAGE’ shows a graphical representation of the genomic
organization of the requested gene (Figure 1B, item 3), with
introns represented as horizontal lines and exons as ﬁlled rect-
angles. An arrow on top of exons indicates that these exons are
potential alternative ﬁrst transcript exons and deﬁne upstream
promoters, whereas the symbol ‘pA’ on top of certain exons
indicates that these exons are deﬁned as potential alternative
last transcript exons under several criteria (see Supplementary
Material). It is important to underline that the ‘pA’ symbol
does not indicate a polyadenylation site position but indicates
only a potential terminal exon. Each represented exon corre-
sponds to the longest exon at this genomic position identiﬁed
among all the different gene transcripts. V-shaped lines above
all exons join the most frequent last position of an exon with
themostfrequentﬁrstpositionofthenextexon.V-shapedlines
below certain exons indicate that these exons or part of them
are differentially included in the ﬁnal gene products.
As mentioned above, several mechanisms allow for differ-
ential selection of the exons (or part of them) that will be
incorporated in the mature transcripts. For a requested gene,
all the differentially selected exons deﬁned by the FAST DB
algorithm (see Materials and Methods and Supplementary
Material) are listed at the bottom of the ‘MAIN PAGE’
(Figure 1B, items 4a, 5 and 6). When several promoters
exist within a given gene, the transcripts generated from the
different promoters differ in their ﬁrst exon. When several
transcription termination sequences and/or polyadenylation
sites exist within a given gene, the transcripts generated differ
in their last exon. Because the ﬁrst and last exons within a
given transcript could result from cloning and sequencing
mistakes, strong criteria must be used in the computerized
deﬁnition of these exons (see Supplementary Material). It is
important to underline that we cannot exclude that upstream or
downstream exons that are absent from the available tran-
scripts actually exist. Therefore, to gain more conﬁdence in
candidate ﬁrst and last exons, we have indicated the number of
transcripts that include every single ﬁrst and last exon
[Figure 1B, items 4a and 5 ‘Number of evidence(s)’]. More-
over, users can perform computer-assisted analyses to look for
other features of ﬁrst exons (e.g. GC content) and last exons
(e.g. polyadenylation sites). By clicking on ‘TRANSCRIP-
TION INITIATION & FIRST EXONS’ (Figure 1B, item
4a), users have access to several website resources (displayed
on the right panel of Figure 1B, item 4b) for promoter and
transcription factor binding site predictions (39–44). Links to
50-UTR analysis website resources are also available, which
provide further information on elements present within can-
didate ﬁrst exons (45–47). Similarly, searches for last exons
features are performed using different website resources acces-
sible through the ‘TRANSCRIPTION TERMINATION &
LAST EXONS’ link (Figure 1B, item 5) that is displayed on
the right panel (3,45–48). Although some of these links direct
users to databases containing pre-deﬁned genes, other tools
analyze a provided sequence. In this case, FAST DB creates a
direct link to the website resource after the user has chosen the
4278 Nucleic Acids Research, 2005, Vol. 33, No. 13Figure 1. FAST DB ‘SEARCH PAGE’ and ‘MAIN PAGE’ corresponding to human GHRHR gene. (A) FAST DB ‘SEARCH PAGE’. (1) Search by keyword; (2)
BLAST search against FAST DB genes; (3) multiple query interface; (4) list of 707 HK genes with a link to FAST DB main page for each of them. (B) FAST DB
‘MAIN PAGE’ corresponding to human GHRHR gene. (1) Link on the navigation banner to display other names and symbols of GHRHR gene and several links to
NCBI,ExPASyandEnsEMBLwebsites;(2)chromosomallocalizationofthegene(linktoUCSCgenomebrowser);(3)graphicalrepresentationofthegene;(4a)list
of alternativefirst exons and links to severalwebsites[displayed on (4b)]forpromoterpredictions,transcriptionfactorbindingsites and 50-UTR analysis;(5)list of
alternativeterminalexonsandlinkstoseveral30-UTRanalysiswebsites;(6)listofalternativesplicingeventsandlinkstootheralternativesplicingdatabases;(7)link
toFASTDBanalysisthatincludeshumanESTs;(8)linktoPUBMED;(9)linktoFASTDBanalysisoftheorthologousmousegene;(10)linkfordownloadingcDNA
andgenomicsequences;(11)onthisgraphicalrepresentation,eachexonorintronisclickabletodisplayitslengthandsequence;(12)linkonthenavigationbannerto
display the graphical representation of the transcripts.
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plus eventually upstream or downstream sequences of differ-
ent sizes. In addition to providing more conﬁdence in candi-
date ﬁrst and last exons, these links let the user search for
known sequences implicated in post-transcriptional regula-
tion, such as transcript stability and translation (3,45–48).
The computerized analysis of the exon content of transcripts
present in public libraries is based on transcript selection
(elimination of bad quality sequences) and on exon deﬁnition.
Because using different criteria has consequences on the ﬁnal
analysis result, clicking on ‘ALTERNATIVE SPLICING’ in
FAST DB provides links to other website resources that con-
tain potential complementary information on transcript exon
content (Figure 1B, item 6) (27–32). Through this link, it is
also possible to access website resources predicting splicing
regulatory sequences within exons (ESEﬁnder and RESCUE-
ESE) (49,50) as well as computer programs that score splicing
sites (FSplice, Gene Splicer and BDGP) (51,52). FAST DB
has created a link that directs the user to the website resource
after choosing sequences corresponding to exons or exon/
intron boundaries.
Because ESTs provide further information regarding differ-
entially selected exons but are potentially of bad quality, an
independent analysis of ESTs is available by clicking on
‘ANALYSIS OF HUMAN GENE WITH ESTs’ (Figure 1B,
item 7). This analysis allows for ‘predicting’ other potential
alternatively spliced exons. Additional information described
in the literature on splicing events for the analyzed gene is
available by clicking on the ‘PUBMED’ link (Figure 1B,
item 8). If a transcript has not been analyzed by FAST DB
or if users identiﬁed a new transcript, the sequence of such
a transcript can be entered from the ‘SEARCH PAGE’
(Figure 1A, item 2). The transcript sequence must be at
least 20 nt long. After clicking the ‘search’ button and check-
ing the ‘Align your sequence with the graphical gene repres-
entation’ box, the input sequence localization is displayed
under the graphical gene representation. The input sequence
is also aligned against the genomic sequence in the ‘in silico
PCR’ page (see below). Finally, for some genes, a similar
analysis for the corresponding mouse orthologous gene is
available by clicking on ‘ANALYSIS OF MOUSE GENE’
for inter-species comparison (Figure 1B, item 9).
In summary, FAST DB offers several ways of obtaining
extensive information on the exons that are differentially
selected within mature transcripts: analysis of full-length
and partial human cDNAs and human ESTs, analysis
of mouse cDNAs, links to other website resources and
PUBMED, and analysis of transcripts entered by the users.
Importantly, all the sequences used by FAST DB can be down-
loaded by clicking on the ‘DOWNLOAD SEQUENCES’
button (Figure 1B, item 10). From this link, it is also possible
to obtain the exonic sequences underlined within the corre-
sponding genomic sequence (data not shown). Alternatively,
the sequence of individual exons or introns can be obtained by
clicking on the graphical representation (Figure 1B, item 11).
Graphical presentation of the transcripts and
in silico PCR
To identify the transcripts used to establish the different events
listed on the ‘MAIN PAGE’, users access the graphical
representation (exon content) of each transcript by clicking
on the ‘TRANSCRIPTS VIEW’ button (Figure 1B, item 12).
This graphical representation provides users with an easy
understanding of the exon content of all known transcripts
produced by the requested gene (Figure 2A, item 1). The
accession number (Figure 2A, item 2), a link to Pubmed
and Genbank (Figure 2A, item 3), and information regarding
the tissues from which the transcripts have been cloned
(Figure 2A, item 4) are available. All the graphical and content
information is easily printable by clicking on the ‘PDF’ button
(Figure 2A, item 5). Altogether, these data provide an excel-
lent tool for scientists designing an experimental approach
to study the expression regulation of the products of a
given gene. To facilitate such studies, FAST DB provides a
speciﬁc tool accessed by clicking on the ‘IN SILICO PCR’
button (Figure 2A, item 6).
The ‘IN SILICO PCR’ link provides users with a multi-
alignment (see Materials and Methods and Supplementary
Material) of all transcript sequences of a given gene
(Figure 2B, item 1). Thanks to this alignment, the speciﬁc
sequences of certain transcripts are distinguished from
the sequences shared by all transcripts (Figure 2B, item 2).
By leaving the cursor a few seconds on the sequence of inter-
est, the corresponding exon number is displayed and the
graphical view of the transcripts printed from the PDF ﬁle
easily compares with the multi-alignment result (Figure 2B,
item 3). In case of a multi-alignment difﬁculty for one of the
transcripts (see Supplementary Material), the alignment of
each transcript sequence against the genomic sequence is
made available by clicking on the accession number of the
transcript on the left of the multi-alignment (Figure 2B,
item 4).
Based on this multi-alignment, it becomes easy to design
PCR primers. As shown in Figure 2B, the user selects
sequences ﬂanking a region that presents alternative splicing
(Figure 2B, item 5). These selected sequences can be copied
andpastedintheprimerboxes (Figure 2B,item 6).Clickingon
the ‘Run PCR’ button brings up information on the sequence,
length, %GC content and Tm of the selected primers
(Figure 2B, item 7). The sizes of the PCR products obtained
from the different transcripts are also provided (Figure 2B,
item 8). Clicking on the ‘sequence’ link on the right
(Figure 2B, item 8) displays the sequence of the PCR product
for the selected transcript (Figure 2B, item 9). This sequence
can be selected and pasted in any computer program for
prediction of restriction enzyme sites either for checking
the nature of the PCR products experimentally obtained or
for cloning purpose.
As described above, users can select primers that ﬂank an
alternative region of a gene to co-amplify different spliced
variants and quantify the effect of a stimulus on the ratio of
different spliced products. Primers can also be selected within
sequences shared by all known transcripts to amplify all the
gene products as a single PCR product and determine the
impact of a transcriptional stimulus taking into account all
the target gene products. Finally, primers can be selected to
speciﬁcally amplify a variant by choosing primers within
speciﬁc sequences of a splice variant. In addition, because
the nameofeach exonappears onthemulti-alignment,primers
can be designed at the junction of exons to avoid ampliﬁcation
of genomic DNA.
4280 Nucleic Acids Research, 2005, Vol. 33, No. 13Figure 2. Graphical representation of GHRHR transcripts, navigationbanner and in silico PCR. (A) Graphical representation of GHRHR transcripts. (1) Graphical
representationoftranscriptalignedwiththegenegraphicalrepresentation;(2)transcriptaccessionnumber;(3)linkstoGenbankandPubmed;(4)nameofthetissue
wherethe transcriptwascloned;(5)linktothe PDFversionofthecurrentGHRHRanalysis;(6)linkto the multi-alignmentoftheGHRHRtranscriptsequencesand
in silico PCR; (7) for each exon, number of transcripts that include/skip the exon. (B) In silico PCR. (1) Multi-alignmentof all GHRHR transcripts performed exon
by exon; (2) variable sequence found in one transcript due to an alternative 50-splice site; (3) current exon and name of the current transcript displayed by pointing
the cursor on the corresponding sequence for a few seconds; (4) transcript accession numbers linked to an alignment of the corresponding transcript sequence with
the genomic sequence; (5) selection of sequences for PCR primers directly on the multi-alignment; (6) selected PCR primer sequences pasted in the corresponding
boxes to run in silico PCR; (7) length, GC% content, Tm and 50–30 sequence of the selected primers; (8) length of the expected PCR product for each transcript and
link to its sequence; (9) sequence of the PCR product within the sequence of the template transcript.
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to predict whether an alternative splicing event would have
biological consequences at the protein level. Users can select a
speciﬁc variable sequence and analyze it with Blastx (http://
www.ncbi.nlm.nih.gov/BLAST/) to test if this sequence
encodes a known protein and with Interpro (http://www.ebi.
ac.uk/interpro/) to test if this sequence encodes a speciﬁc
protein domain.
Analysis of HK genes
Because HK genes are widely expressed across tissues, studies
of gene expression regulation are often performed using HK
genes as internal control (35–38). Interestingly, the genomic
organization of HK genes has recently been shown to be dif-
ferent from that of tissue-speciﬁc (TS) expressed genes
(37,38). HK genes are usually more ‘compact’ than TS genes,
mostly because of the smaller size of their introns and because
HK genes have fewer exons/introns than TS genes. Neverthe-
less, to our knowledge, there is no general information avail-
able regarding the potential ability of HK genes to generate
multiple transcripts. Because HK genes are essential in tran-
scriptional studies, we have set up an analysis of HK gene
products in FAST DB. For this purpose, we used 707 HK
genes that had been deﬁned in previous reports based on
their wide expression in many tissues (35–38).
Analyzing allthegenes (other thatHKgenes)presentwithin
FAST DB, we observed that 3458 genes ( 28%) out of 12538
analyzed genes contain at least two alternative ﬁrst exons and
2414 genes ( 19%) contain at least two different last exons
(Figure 3). Our analysis did not take into account the different
polyadenylation sites within a single exon, which would
signiﬁcantly increase the percentage of transcripts having dif-
ferential 30 end (3–5). The most frequently occurring alterna-
tive splicing event was ‘exon skipping’. Half of the analyzed
genes contain at least one exon that was skipped. About 26%
ofthe analyzed genes contain at least one exonwithalternative
50 end and 25% of the analyzed genes contain at least one exon
with alternative 30 end. About 15% of the analyzed genes
contain at least one intron that was retained within a transcript.
These results, which are consistent with those of other
analyzes (6–9,12–14,27–32), demonstrate that the capability
of human genes to generate different transcripts is a rule and
not an exception because 66% of human genes generate at
least two different transcripts having different exon content.
Using the set of 707 HK genes, we conﬁrmed previous
ﬁndings that HK genes contain fewer exons than other
genes (two introns fewer in average) and that small (<10 kb)
HK genes are more frequent compared with small TS genes
(20% versus 10%, respectively). Nevertheless, we observed
that HK genes can generate multiple transcripts similarly to
TS genes (Figure 3). Half of HK genes contain at least one
exon cassette (Figure 3). About one-third of HK genes gen-
erate products with different 50-alternative spliced sites and a
similar proportion of these genes contains 30-alternative
spliced sites. About 22% of HK genes contain at least one
intron retained in a mature transcript. Interestingly, although
one-third of HK and TS genes contain multiple ﬁrst exons, we
observed that only 11% of HK genes contain multiple terminal
exons compared with  19% of TS genes.
In conclusion, despite a different genomic organization, HK
genes are able to generate transcript diversity at a similar level
to that of TS genes. Therefore, caution is required in designing
primers when HK genes are used as transcription internal
controls because the exon content of HK gene products
might vary depending on the biological conditions. To help
users select primers and avoid alternative regions in these
genes, the list of 707 HK genes is accessed by clicking the
‘List of housekeeping genes’ link on the FAST DB ‘SEARCH
PAGE’ (Figure 1A, item 4).
DISCUSSION
FAST DB has been designed to facilitate the study of the
expression regulation of the various transcripts produced by
human genes. This goal was achieved by: (i) a clear and
‘intuitive’ presentation of the information. (ii) The most com-
plete set of information on the nature of the transcripts pro-
duced by human genes based on the analysis of full-length and
partial cDNAs, as well as human ESTs. Links to other public
databases that contain potential complementary information
on the nature of transcripts produced by human genes are
included. The possibility for users to enter their own transcript
Figure 3. AppearanceofalternativeeventsinproducingdifferenttranscriptsfromHKversusTSgenes.Thehorizontalaxisdefinescategoriesofalternativeevents.
The vertical bars represent the proportion (%) of TS genes (white bars) and HK genes (shaded bars) affected at least once by the alternative event.
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able. The analysis of mouse orthologous genes is provided for
inter-species comparison. (iii) A sequence multi-alignment of
all transcripts produced by a single gene, which facilitates the
design of probes for downstream experiments. (iv) A link to a
‘List of housekeeping genes’ to help users design primers that
are used as internal controls. The rationale is based on our
observation that HK genes generate transcripts of different
exonic content. (v) Links to website resources for promoter
analysis and transcriptional factor binding site predic-
tions, splicing regulatory sequence prediction, as well as for
50- and 30-UTR analysis, which facilitate studies integrating
transcriptional and post-transcriptional aspects.
Knowing the exon content of transcripts is required for
understanding the biological consequences of transcriptional
stimuli. Indeed, genes cannot be longer considered as ‘simple’
functional units. Genes are rather an ‘assemblage’ of exons
that are differentially incorporated within the gene products
that in turn generate protein isoforms with different biological
activities or functions. The FAST DB analysis has been per-
formed on 12538 human genes deﬁning 151747 exons and we
estimated that 31318 exons are subject to regulation. This
means that  20% of total human exons are differentially
integrated within gene products. This proportion is probably
underestimated because the statistical analysis was performed
using only full or partial cDNAs present within public
libraries. This large amount of exons differentially incorpo-
rated within gene products is in good agreement with the poor
deﬁnition of exon and intron boundaries, which creates the
right conditions for physiological regulation and evolution
(8,10,53–55).
AVAILABILITY
FAST DB is freely available on the internet at http://193.48.
40.18/fastdb/.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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